Does Apple View Itself as a Value or Growth Company?

Does Apple View Itself as a Value or Growth Company?

Assessment

Interactive Video

Business, Health Sciences, Architecture, Biology

University

Hard

Created by

Wayground Content

FREE Resource

The video discusses Apple's shift from a growth to a value company, emphasizing its loyal customer base and stock valuation. It explores Apple's R&D investments and potential new product categories, questioning the effectiveness of these investments. The discussion also covers Apple's long-term strategy, focusing on services and market positioning, and considers the risks and potential of acquisitions.

Read more

7 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the current perception of Apple in terms of its market position?

A declining company

A startup

A value company

A growth company

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the estimated lifetime value of an iPhone customer according to the discussion?

$1500

$1000

$2000

$500

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which areas is Apple reportedly exploring with its R&D investments?

Space exploration

Renewable energy

China, automobiles, and virtual reality

Healthcare and fitness

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the main focus of Apple's current strategy according to the discussion?

Expanding retail stores

Developing new hardware

Monetizing its install base through services

Reducing production costs

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What percentage of Apple's revenue is currently generated by services?

15-17%

5-7%

20-22%

10-12%

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a potential risk for Apple if it decides to make large acquisitions?

High financial risk

Loss of brand identity

Increased competition

Regulatory challenges

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why has Apple not made significant large acquisitions according to the discussion?

Regulatory restrictions

Focus on internal development

High risk and not in their DNA

Lack of suitable targets